DigiM provides advanced microstructure characterization for pharmaceutical intermediates and products. Through 3D imaging analytics, we correlate microstructures with manufacturing, formulation, and performance. Our image-based release simulation provides unprecedented performance prediction for controlled and long-acting dosage forms. DigiM partners with leading pharmaceutical innovators, delivering insight to advance development and formulation decisions.
67 South Bedford Street
Suite 400 West
Burlington, Massachusetts 01803